155 related articles for article (PubMed ID: 17803849)
1. [Factors influencing the survival of patients with skull base chordoma].
Zhang JT; Wang L; Wu Z; Jia GJ; Zhang LW
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1607-10. PubMed ID: 17803849
[TBL] [Abstract][Full Text] [Related]
2. [Treatment modalities and prognostic factors of chordoma in the skull base].
Qian LT; Liu XF; Li YX
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):635-7. PubMed ID: 16438879
[TBL] [Abstract][Full Text] [Related]
3. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy.
Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE
Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and pathological study of chordoma in the skull base].
Nong H; Nong D; Nong X; Teng Y; Liang Y; Wu H; Wen W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):99-102. PubMed ID: 12768716
[TBL] [Abstract][Full Text] [Related]
5. Cranial base chordoma--long term outcome and review of the literature.
Yoneoka Y; Tsumanuma I; Fukuda M; Tamura T; Morii K; Tanaka R; Fujii Y
Acta Neurochir (Wien); 2008 Aug; 150(8):773-8; discussion 778. PubMed ID: 18548191
[TBL] [Abstract][Full Text] [Related]
6. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
[TBL] [Abstract][Full Text] [Related]
7. Skull base chordoma.
Mendenhall WM; Mendenhall CM; Lewis SB; Villaret DB; Mendenhall NP
Head Neck; 2005 Feb; 27(2):159-65. PubMed ID: 15641104
[TBL] [Abstract][Full Text] [Related]
8. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
[TBL] [Abstract][Full Text] [Related]
9. Residual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine.
Potluri S; Jefferies SJ; Jena R; Harris F; Burton KE; Prevost AT; Burnet NG
Clin Oncol (R Coll Radiol); 2011 Apr; 23(3):199-208. PubMed ID: 20980136
[TBL] [Abstract][Full Text] [Related]
10. Male sex as a risk factor for the clinical course of skull base chordomas.
Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
[TBL] [Abstract][Full Text] [Related]
11. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
[TBL] [Abstract][Full Text] [Related]
12. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities.
Jahangiri A; Chin AT; Wagner JR; Kunwar S; Ames C; Chou D; Barani I; Parsa AT; McDermott MW; Benet A; El-Sayed IH; Aghi MK
Neurosurgery; 2015 Feb; 76(2):179-85; discussion 185-6. PubMed ID: 25594191
[TBL] [Abstract][Full Text] [Related]
15. Tumour Volume and Dose Influence Outcome after Surgery and High-dose Photon Radiotherapy for Chordoma and Chondrosarcoma of the Skull Base and Spine.
Gatfield ER; Noble DJ; Barnett GC; Early NY; Hoole ACF; Kirkby NF; Jefferies SJ; Burnet NG
Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):243-253. PubMed ID: 29402600
[TBL] [Abstract][Full Text] [Related]
16. Effect comparisons among treatment measures on progression-free survival in patients with skull base chordomas: a retrospective study of 234 post-surgical cases.
Wang L; Tian K; Ma J; Wang K; Jia G; Wu Z; Zhang L; Zhang J
Acta Neurochir (Wien); 2017 Oct; 159(10):1803-1813. PubMed ID: 28699066
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor and c-MET in skull base chordoma.
Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A
Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of prognosis of skull base chordoma treated by surgical resection and gamma knife surgery].
Shu Z; Hou Y; Wang Y; Tang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):359-62. PubMed ID: 21566291
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the BMP4/SMAD signaling pathway in skull base chordomas is associated with poor prognosis.
Feng Y; Zhang Q; Wang Z; Yan B; Wei W; Li P
Int J Clin Exp Pathol; 2015; 8(7):8268-75. PubMed ID: 26339396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]